Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Teads Holding (TEAD) Asset Writedowns and Impairment (2025)

Teads Holding (TEAD) has disclosed Asset Writedowns and Impairment for 1 consecutive years, with $352.1 million as the latest value for Q4 2025.

Quarterly Asset Writedowns and Impairment changed N/A to $352.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $367.7 million through Dec 2025, changed N/A year-over-year, with the annual reading at $367.7 million for FY2025, N/A changed from the prior year.
Asset Writedowns and Impairment for Q4 2025 was $352.1 million at Teads Holding, up from $15.6 million in the prior quarter.
The five-year high for Asset Writedowns and Impairment was $352.1 million in Q4 2025, with the low at $15.6 million in Q1 2025.